Have just filled my latest accumulation - 150,000 @ 31 .
This isn't about bragging but to demonstrate my utter conviction as a professional investor that the Adapt portfolio is growing and so are the sales of each of it's parts (CC, Neo, VC - and soon 3D) in the US and Europe (then add on India).
This is a many headed Hydra whose total sales won't just be increasing, but squaring and cubing, year on year.
We will be permanently profitable from Q1 FY18.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-196
-
- There are more pages in this discussion • 155 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.50 |
Change
-0.400(3.10%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $12.71 | $12.71 | $12.30 | $131.3K | 10.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 85 | $11.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.50 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |